Physician profile
Philip Jay Rosenblum
NPI 1295732022
$17,687.49
in general payments reported to CMS, 2019-2025
83 companies · $2,601 in 2025
The $2,601 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,345 · 2020: $1,813 · 2021: $2,826 · 2022: $2,818 · 2023: $2,667 · 2024: $2,617 · 2025: $2,601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,885.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,182.68 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals LP | $2,289.93 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $1,680.93 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,432.35 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $1,109.93 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $1,035.88 | 2019-2025 | |
| Glaxosmithkline, LLC. | $870.71 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $498.60 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $492.21 | 2019-2024 | Xarelto, Spravato |
| Medtronic, INC. | $381.11 | 2021-2025 | Symplicity G3, Inceptiv |
| Amgen INC. | $366.41 | 2019-2025 | Otezla, Repatha, Evenity |
| Abbott Laboratories | $362.61 | 2021-2025 | Freestyle Libre 3, Proclaim, Eterna |
| Novartis Pharmaceuticals Corporation | $355.21 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $301.28 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Sanofi-Aventis U.S. LLC | $251.92 | 2019-2025 |
Show all 83 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $216.16 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $152.33 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $147.30 | 2019-2024 | Rexulti |
| Allergan, INC. | $130.13 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $126.72 | 2019-2024 | Xifaxan, Trulance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $112.27 | 2025 | Caplyta |
| Grifols USA, LLC | $109.70 | 2021-2025 | Prolastin-C Liquid |
| Amarin Pharma, INC. | $105.99 | 2020-2021 | |
| Axsome Therapeutics, INC. | $87.19 | 2025 | Symbravo |
| Astellas Pharma US INC | $83.90 | 2021-2024 | Veozah |
| Eisai INC. | $82.30 | 2020-2025 | |
| Vanda Pharmaceuticals INC. | $81.85 | 2021-2023 | Hetlioz, Fanapt |
| Cranial Technologies, INC | $71.19 | 2020-2025 | Doc Band |
| Dexcom, INC. | $63.64 | 2023-2024 | Dexcom G6 Transmitter |
| Medtronic Minimed, INC. | $63.32 | 2019-2020 | |
| Hologic Sales and Service, LLC | $62.69 | 2022-2025 | Aptima, Thinprep 2000 Processor |
| Takeda Pharmaceuticals U.S.A., INC. | $61.48 | 2019-2021 | |
| Edwards Lifesciences Corporation | $55.41 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Si-Bone, INC. | $54.75 | 2021-2024 | |
| Ibsa Pharma INC. | $47.41 | 2019-2024 | Licart, Flector, Tirosint |
| Genentech USA, INC. | $46.59 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $43.98 | 2019-2020 | |
| Corium, LLC | $42.72 | 2023 | Azstarys |
| Idorsia Pharmaceuticals US INC | $42.14 | 2022-2024 | Quviviq |
| Boston Scientific Corporation | $40.96 | 2020-2025 | General - Therapies |
| Biogen, INC. | $40.89 | 2019-2024 | Skyclarys |
| Horizon Therapeutics Plc | $37.91 | 2021-2022 | |
| Cleerly, INC. | $37.64 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Gilead Sciences, INC. | $36.70 | 2019 | |
| Philips North America LLC | $35.33 | 2024 | (Ck7) Extended Holter |
| Jazz Pharmaceuticals INC. | $34.25 | 2021 | |
| Exact Sciences Corporation | $28.17 | 2025 | Cologuard Collection Kit |
| Currax Pharmaceuticals LLC | $28.08 | 2024-2025 | Contrave |
| Seqirus USA INC | $27.64 | 2025 | Flucelvax |
| Coopersurgical, INC. | $26.17 | 2021-2023 | Paragard T 380a |
| Alexion Pharmaceuticals, INC. | $24.95 | 2025 | Strensiq |
| Esperion Therapeutics, INC. | $23.81 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $23.42 | 2022 | |
| Abiomed | $23.35 | 2024 | Impella |
| Ani Pharmaceuticals, INC. | $23.00 | 2025 | Purified Cortrophin Gel |
| Phadia US INC. | $22.92 | 2023 | Immunocap |
| Optinose US, INC. | $22.56 | 2022 | |
| Baxter Healthcare | $22.55 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Vbi Vaccine (Delaware) INC. | $22.21 | 2022 | |
| Phathom Pharmaceuticals, INC. | $21.20 | 2024 | Voquezna |
| Organon LLC | $21.12 | 2024 | |
| Corcept Therapeutics | $21.00 | 2021 | |
| Lundbeck LLC | $20.88 | 2022 | |
| Inspire Medical Systems, INC. | $20.04 | 2025 | Inspire |
| Zealand Pharma US, INC. | $19.56 | 2020 | |
| Cequr Corporation | $19.56 | 2024 | Cequr Simplicity |
| Daiichi Sankyo INC. | $19.28 | 2020 | |
| Kaleo, INC. | $18.16 | 2022 | |
| Bioventus LLC | $17.88 | 2019 | |
| Medtronic USA, INC. | $17.52 | 2019 | |
| Paratek Pharmaceuticals, INC. | $16.87 | 2025 | Nuzyra |
| Nevro Corp. | $16.63 | 2022 | |
| Sanofi Pasteur INC. | $16.12 | 2019 | |
| Heartflow, INC. | $16.05 | 2022 | |
| Sunovion Pharmaceuticals INC. | $15.81 | 2021 | |
| Neurocrine Biosciences, INC. | $14.82 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $14.82 | 2019 | |
| Shire North American Group INC | $14.17 | 2019 | |
| Shield Therapeutics INC | $12.87 | 2023 | Accrufer |
| Therapeuticsmd, INC. | $12.45 | 2019 | |
| Impel Pharmaceuticals INC. | $12.16 | 2022 | |
| Linus Health, INC. | $12.05 | 2024 | Core Cognitive Evaluation |
| Dysis Medical, INC. | $11.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Rosenblum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.